Dallas children's hospital relocates patients after finding mold

Children's Medical Center Dallas relocated 28 patients after routine air tests


Children's Medical Center Dallas recently relocated 28 patients after routine air tests showed higher-than-normal levels of Aspergillus and Penicillium molds, according to an article on the CNN website.

The patients were moved from the cardiac intensive care unit at Children's Medical Center Dallas to other parts of the facility.

No patients have become infected and none have experienced any health effects as a result of the mold, the hospital said.

No previous tests at the hospital showed mold outside the expected ranges, according to a spokesperson. There is an ongoing investigation into last week's test results.

Read the article.



December 17, 2019


Topic Area: Infection Control


Recent Posts

Resilience Planning in Remote Healthcare Facilities

Assumptions about equipment failures and response times change when a hospital is hundreds of miles from the nearest major city.


Missouri Southern State University Opens Roy Blunt Health Science Innovation Center

The project broke ground in April 2024.


HCA Florida Unveils Plans for New Cape Coral Hospital

The planned hospital will be located where HCA Florida Cape Coral Emergency currently operates.


5 Reasons Engineering is the Edge in Healthcare Master Planning

The most successful plans go further to unlock smarter investments, improve resilience and enable better patient outcomes.


Building an AI-Ready Healthcare Facility 

Creating a secure, standardized data foundation can help facilities teams put AI to work more effectively.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.